The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus

Virology

Volumn 371, Issue 2, 2008, Pages 246-256

  Kutz, Helmut ^a   Reisbach, Gilbert ^a   Schultheiss, Ute ^a   Kieser, Arnd ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

c Jun N terminal kinase (JNK); Cell cycle; Epstein Barr virus (EBV); JNK inhibitor; Latent membrane protein 1 (LMP1); Transformation; Tumor

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLIN DEPENDENT KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; EPSTEIN BARR VIRUS; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; VIRUS CELL INTERACTION;

ANIMALS; ANTHRACENES; B-LYMPHOCYTES; CELL LINE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FIBROBLASTS; HERPESVIRUS 4, HUMAN; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, SCID; MITOGEN-ACTIVATED PROTEIN KINASE 8; RATS; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4; MUS;

EID: 38649085620     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.09.044     Document Type: Article

References (49)

1. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 98 24 (2001) 13681-13686
2. Brinkmann M.M., and Schulz T.F. Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae. J. Gen. Virol. 87 Pt5 (2006) 1047-1074
3. Cahir McFarland E.D., Izumi K.M., and Mosialos G. Epstein-Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. Oncogene 18 49 (1999) 6959-6964
4. Dawson C.W., Tramountanis G., Eliopoulos A.G., and Young L.S. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J. Biol. Chem. 278 6 (2003) 3694-3704
5. Dirmeier U., Neuhierl B., Kilger E., Reisbach G., Sandberg M.L., and Hammerschmidt W. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by Epstein-Barr virus. Cancer Res. 63 11 (2003) 2982-2989
6. Dirmeier U., Hoffmann R., Kilger E., Schultheiss U., Briseno C., Gires O., Kieser A., Eick D., Sugden B., and Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24 10 (2005) 1711-1717
7. Du L., Lyle C.S., Obey T.B., Gaarde W.A., Muir J.A., Bennett B.L., and Chambers T.C. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent. J. Biol. Chem. 279 12 (2004) 11957-11966
8. Eliopoulos A.G., and Young L.S. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 16 13 (1998) 1731-1742
9. Eliopoulos A.G., Gallagher N.J., Blake S.M., Dawson C.W., and Young L.S. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J. Biol. Chem. 274 23 (1999) 16085-16096
10. Eliopoulos A.G., Waites E.R., Blake S.M., Davies C., Murray P., and Young L.S. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40. J. Virol. 77 2 (2003) 1316-1328
11. Everly Jr. D.N., Mainou B.A., and Raab-Traub N. Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J. Virol. 78 24 (2004) 13470-13478
12. Floettmann J.E., and Rowe M. Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation. Oncogene 15 15 (1997) 1851-1858
13. Floettmann J.E., Ward K., Rickinson A.B., and Rowe M. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 223 1 (1996) 29-40
14. Gaillard P., Jeanclaude-Etter I., Ardissone V., Arkinstall S., Cambet Y., Camps M., Chabert C., Church D., Cirillo R., Gretener D., Halazy S., Nichols A., Szyndralewiez C., Vitte P.A., and Gotteland J.P. Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase. J. Med. Chem. 48 14 (2005) 4596-4607
15. Gires O., Zimber-Strobl U., Gonnella R., Ueffing M., Marschall G., Zeidler R., Pich D., and Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 16 20 (1997) 6131-6140
16. Gururajan M., Chui R., Karuppannan A.K., Ke J., Jennings C.D., and Bondada S. c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells. Blood 106 4 (2005) 1382-1391
17. He Z., Xin B., Yang X., Chan C., and Cao L. Nuclear factor-kappaB activation is involved in LMP1-mediated transformation and tumorigenesis of rat-1 fibroblasts. Cancer Res. 60 7 (2000) 1845-1848
18. Huang W., Batra S., Korrapati S., Mishra V., and Mehta K.D. Selective repression of low-density lipoprotein receptor expression by SP600125: coupling of histone H3-Ser10 phosphorylation and Sp1 occupancy. Mol. Cell. Biol. 26 4 (2006) 1307-1317
19. Karin M., and Gallagher E. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57 4-5 (2005) 283-295
20. Kavathas P., Bach F.H., and DeMars R. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc. Natl. Acad. Sci. U. S. A. 77 7 (1980) 4251-4255
21. Kaye K.M., Izumi K.M., and Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. U. S. A. 90 19 (1993) 9150-9154
22. Kieser A. Signal transduction by the Epstein-Barr virus oncogene latent membrane protein 1 (LMP1). Signal Transduct. 7 1 (2007) 20-33
23. Kieser A., Kilger E., Gires O., Ueffing M., Kolch W., and Hammerschmidt W. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J. 16 21 (1997) 6478-6485
24. Kieser A., Kaiser C., and Hammerschmidt W. LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2. EMBO J. 18 9 (1999) 2511-2521
25. Kilger E., Kieser A., Baumann M., and Hammerschmidt W. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17 6 (1998) 1700-1709
26. Kulwichit W., Edwards R.H., Davenport E.M., Baskar J.F., Godfrey V., and Raab-Traub N. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 95 20 (1998) 11963-11968
27. Kuppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev., Immunol. 3 10 (2003) 801-812
28. Liang J., and Slingerland J.M. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2 4 (2003) 339-345
29. Luftig M., Prinarakis E., Yasui T., Tsichritzis T., Cahir-McFarland E., Inoue J., Nakano H., Mak T.W., Yeh W.C., Li X., Akira S., Suzuki N., Suzuki S., Mosialos G., and Kieff E. Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6. Proc. Natl. Acad. Sci. U. S. A. 100 26 (2003) 15595-15600
30. Mainou B.A., Everly D.N., and Raab-Traub N. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 24 46 (2005) 6917-6924
31. Mechta-Grigoriou F., Gerald D., and Yaniv M. The mammalian Jun proteins: redundancy and specificity. Oncogene 20 19 (2001) 2378-2389
32. Moorthy R.K., and Thorley-Lawson D.A. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J. Virol. 67 3 (1993) 1638-1646
33. Morita S., Kojima T., and Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7 12 (2000) 1063-1066
34. Polack A., Hortnagel K., Pajic A., Christoph B., Baier B., Falk M., Mautner J., Geltinger C., Bornkamm G.W., and Kempkes B. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1. Proc. Natl. Acad. Sci. U. S. A. 93 19 (1996) 10411-10416
35. Schultheiss U., Puschner S., Kremmer E., Mak T.W., Engelmann H., Hammerschmidt W., and Kieser A. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. EMBO J. 20 20 (2001) 5678-5691
36. Schwieger M., Lohler J., Friel J., Scheller M., Horak I., and Stocking C. AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency. J. Exp. Med. 196 9 (2002) 1227-1240
37. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4 5 (2002) E131-E136
38. Smeal T., Binetruy B., Mercola D.A., Birrer M., and Karin M. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354 6353 (1991) 494-496
39. Stevenson D., Charalambous C., and Wilson J.B. Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9. Cancer Res. 65 19 (2005) 8826-8835
40. Sunters A., Madureira P.A., Pomeranz K.M., Aubert M., Brosens J.J., Cook S.J., Burgering B.M., Coombes R.C., and Lam E.W. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. Cancer Res. 66 1 (2006) 212-220
41. Thorley-Lawson D.A. Epstein-Barr virus: exploiting the immune system. Nat. Rev., Immunol. 1 1 (2001) 75-82
42. Vockerodt M., Haier B., Buttgereit P., Tesch H., and Kube D. The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway. Virology 280 2 (2001) 183-198
43. Vogt P.K. Jun, the oncoprotein. Oncogene 20 19 (2001) 2365-2377
44. Wada T., Joza N., Cheng H.Y., Sasaki T., Kozieradzki I., Bachmaier K., Katada T., Schreiber M., Wagner E.F., Nishina H., and Penninger J.M. MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence. Nat. Cell Biol. 6 3 (2004) 215-226
45. Wan J., Sun L., Mendoza J.W., Chui Y.L., Huang D.P., Chen Z.J., Suzuki N., Suzuki S., Yeh W.C., Akira S., Matsumoto K., Liu Z.G., and Wu Z. Elucidation of the c-Jun N-terminal kinase pathway mediated by Epstein-Barr virus-encoded latent membrane protein 1. Mol. Cell. Biol. 24 1 (2004) 192-199
46. Wang D., Liebowitz D., and Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43 3 Pt 2 (1985) 831-840
47. Watson A., Eilers A., Lallemand D., Kyriakis J., Rubin L.L., and Ham J. Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. J. Neurosci. 18 2 (1998) 751-762
48. Xie P., Hostager B.S., and Bishop G.A. Requirement for TRAF3 in Signaling by LMP1 But Not CD40 in B Lymphocytes. J. Exp. Med. 199 5 (2004) 661-671
49. Young L.S., and Rickinson A.B. Epstein-Barr virus: 40 years on. Nat. Rev., Cancer 4 10 (2004) 757-768